FDA NDC Directory · JSON-LD · Markdown

OXLUMO

NDC 71336-1002 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namelumasiran
Labeler / ManufacturerAlnylam Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214103
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsLUMASIRAN SODIUM (94.5 mg/.5mL)
Marketing started20201123
Package count1

External sources

Source: openFDA. Public-domain (CC0).